Mangoceuticals, Inc.
MGRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $4 | $61 | $60 |
| - Cash | $0 | $1 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $4 | $61 | $60 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | -15.8% | 8,083.2% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.7% | 59% | 54.3% | – |
| EBITDA | -$8 | -$8 | -$2 | -$0 |
| % Margin | -1,292.8% | -1,106.4% | -22,236.5% | – |
| Net Income | -$9 | -$9 | -$2 | -$0 |
| % Margin | -1,413.6% | -1,259.4% | -22,352.1% | – |
| EPS Diluted | -4.399 | -8.58 | -1.731 | -0.018 |
| % Growth | 48.7% | -395.7% | -9,679.1% | – |
| Operating Cash Flow | -$5 | -$7 | -$1 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$5 | -$7 | -$1 | -$0 |